2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Leukemia
17
Breast Neoplasms
14
Rectal Neoplasms
7
Neoplastic Cells, Circulating
7
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Colorectal Neoplasms
7
Colonic Neoplasms
7
Prostatic Neoplasms
6
Head and Neck Neoplasms
6
Kidney Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Congenital Abnormalities
4
Wilms Tumor
3
Neoplasms, Plasma Cell
3
Carcinoma, Renal Cell
3
Carcinoma, Intraductal, Noninfiltrating
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Ovarian Neoplasms
2
Melanoma
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Surveys and Questionnaires
16
Bevacizumab
14
Cisplatin
12
Blood Specimen Collection
11
Drug Therapy
10
Standard of Care
9
Nivolumab
9
Gemcitabine
9
Cetuximab
7
pembrolizumab
6
Specimen Handling
6
S 1 (combination)
6
Endoscopic Mucosal Resection
6
Cyclophosphamide
6
atezolizumab
5
Sunitinib
5
Radiotherapy
5
Folfox protocol
5
Educational Status
5
Docetaxel
5
fludarabine
4
aldesleukin
4
Radiosurgery
4
Pemetrexed
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Reverse Transcriptase Polymerase Chain Reaction
×
Clear all
NCT04379232
2020-05-07
SurgiCovid
Hospices Civils de Lyon
Completed
112 enrolled